Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Aralez Pharmaceuticals logo

Aralez Pharmaceuticals

Recent Finacing

Hybrid

Recent Raise

$300M

Aralez Pharmaceuticals commercializes and develops drugs from POZEN and Tribute assets, establishing a U.S. commercial presence, launching pipeline products including YOSPRALA, and pursuing licensing and acquisitions.

Founded 1996
New York, United States
101-250
Publicly Traded
aralez.com

Highlights

Focus Areas

Alternative Medicine
Biotechnology
Health Care
Medical

Recent Investors

Deerfield Management logo

Financials

$300M

Total Raised

1

Funding round

1

Investor